Results 41 to 50 of about 4,794 (200)

Morphea, Eosinophilic Fasciitis and Cancer: A Scoping Review

open access: yes, 2023
Morphea is an autoimmune fibrotic skin disease. Eosinophilic fasciitis (EF) is considered to belong to the severe spectrum of morphea. We conducted a scoping review assessing the risk of secondary cancer among morphea/EF patients, paraneoplastic morphea ...
Mohammed Osman   +10 more
core   +1 more source

Morphea profunda presenting as a neuromuscular mimic. [PDF]

open access: yes, 2008
Contains fulltext : 70571.pdf (Publisher’s version ) (Open Access)Localized scleroderma is characterized by idiopathic fibrosis of the skin and adjacent structures, and muscle involvement occurs predominantly in deep morphea.
Jong, E.M.G.J. de   +5 more
core   +1 more source

Paediatric Melanonychia: Diagnosis and Management

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Longitudinal melanonychia (LM) in children presents unique diagnostic and management challenges that cannot be adequately addressed by applying adult‐based criteria. Unlike in adults, there are no validated clinical, dermoscopic or histopathologic criteria for predicting nail unit melanoma in the paediatric population.
Angela J. Jiang   +5 more
wiley   +1 more source

Morphea and Eosinophilic Fasciitis: An Update [PDF]

open access: yes, 2017
Contains fulltext : 177167.pdf (Publisher’s version ) (Open Access)Morphea, also known as localized scleroderma, encompasses a group of idiopathic sclerotic skin diseases.
Jong, E.M.G.J. de   +9 more
core   +2 more sources

Genomics and epigenomics of tissue repair: Implications for personalized medicine

open access: yesPrecision Medical Sciences, EarlyView.
Genomic and epigenomic mechanisms govern tissue repair and regeneration through dynamic regulation of inflammation, cell fate, and extracellular matrix remodeling. The integration of multi‐omics, artificial intelligence, and precision regenerative therapies enables biomarker‐driven, personalized approaches to enhance healing and minimize fibrosis ...
Jharna Medhi   +7 more
wiley   +1 more source

Patient and physician satisfaction with video consultations in dermatology: An exploratory cross‐sectional study

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and Objectives Teledermatology has become an essential part of dermatological care, although challenges in its implementation remain. We conducted a real‐life survey on video consultations over a one‐year period to assess satisfaction and identify barriers.
Felix von Krogh   +4 more
wiley   +1 more source

Plaque psoriasis and morphea in a patient on ustekinumab: A case report

open access: yesSAGE Open Medical Case Reports, 2023
A large number of autoimmune and fibrosing conditions associated with psoriasis and morphea have been reported in the literature. Currently, the relationship between psoriasis and morphea is unknown, and the coexistence of these conditions is quite rare.
Katrina Cirone, Ronald Vender
doaj   +1 more source

Cutaneous lymphomas – an update

open access: yesHistopathology, EarlyView.
Primary cutaneous lymphomas and lymphoproliferative disorders are defined by integrated clinical, histopathological, immunophenotypic and genetic features as diagnostic criteria also in the 5th edition of the WHO classification of haematolymphoid tumors.
Werner Kempf, Christina Mitteldorf
wiley   +1 more source

Hemorrhagic bullous lesions in morphea

open access: yes, 1989
The case of a 20-year-old girl who had morphea with bullous lesions is reported. Two bullae appeared on an indurated patch of morphea on the right side of the trunk.
Bardazzi, F, Tosti, A, Melino, M
core   +2 more sources

Immune checkpoint inhibitor‐induced eosinophilic fasciitis: A pharmacovigilance and EADV Task force study

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
A comprehensive retrospective analysis of 121 immune checkpoint inhibitor‐induced eosinophilic fasciitis cases, including clinical presentation, diagnostic features and treatment outcomes using data from the EADV Task Force ‘Dermatology for Cancer Patients’, two international pharmacovigilance databases and the current literature.
Tristan V. M. Bruijn   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy